Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Frontiers of Medicine|October 4, 2011
The unregulated commercialization of stem cell treatments: a global perspectiveDouglas SippCell Stem Cell|October 3, 2009
Gold standards in the diamond age: the commodification of pluripotencyDouglas SippCell Stem Cell|February 4, 2018
Japan Strengthens Regenerative Medicine OversightDouglas Sipp, Hideyuki OkanoCell Stem Cell|May 11, 2010
Regulatory impacts on stem cell research in JapanMasahiro Kawakami, Douglas Sipp, Kazuto KatoScience (New York, N.Y.)|August 24, 2013
Tissue interactions in neural crest cell development and diseaseYoshiko Takahashi, Douglas Sipp, Hideki EnomotoNPJ Regenerative Medicine|February 27, 2018
Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventionsClaire Horner, Evelyn Tenenbaum, Douglas Sipp, et al.Cell Stem Cell|December 11, 2012
Ethical and policy issues in the clinical translation of stem cells: report of a focus session at the ISSCR Tenth Annual MeetingKazuto Kato, Jonathan Kimmelman, Jason Robert, et al.Cell Stem Cell|July 7, 2023
Too little, too soon: Japan's experiment in regenerative medicine deregulationDavid Cyranoski, Douglas Sipp, Shreyashee Mallik, et al.Pageof 5